Stock Comparison

URGN vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricURGNUroGen Pharma Ltd.AAPLApple Inc.
Market Cap$914.65M$3.8T
Current Price$19.54$258.21
P/E Ratio-6.6034.61
Revenue Growth 1Y9.3%6.4%
Net Margin-140.4%26.9%
ROE171.4%
ROIC70.6%
Debt/Equity1.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

URGN vs AAPL: Key Questions Answered

Which stock is growing the fastest: URGN or AAPL?

UroGen Pharma Ltd. (URGN) is growing the fastest with 9.3% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: URGN or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. UroGen Pharma Ltd. has the lowest at -1.4%. Higher margins indicate pricing power and efficiency.

Which is the largest company: URGN or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. UroGen Pharma Ltd. is the smallest at $0.9B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: URGN or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. UroGen Pharma Ltd. has the lowest at 0.0%. Higher ROE indicates efficient use of capital.